Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aditxt Inc (ADTX)

Aditxt Inc (ADTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 25,263
  • Shares Outstanding, K 14,688
  • Annual Sales, $ 0 K
  • Annual Income, $ -9,150 K
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 4.36
Trade ADTX with:

Options Overview Details

View History
  • Implied Volatility 143.76%
  • Historical Volatility 66.66%
  • IV Percentile 53%
  • IV Rank 37.91%
  • IV High 230.05% on 09/15/21
  • IV Low 91.09% on 07/22/21
  • Put/Call Vol Ratio 0.14
  • Today's Volume 251
  • Volume Avg (30-Day) 4,396
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 12,645
  • Open Int (30-Day) 19,967

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.05
  • Number of Estimates 1
  • High Estimate -0.05
  • Low Estimate -0.05
  • Prior Year N/A
  • Growth Rate Est. (year over year) -100.01%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.5150 +13.53%
on 09/21/21
3.9500 -56.46%
on 08/25/21
-0.2600 (-13.13%)
since 08/24/21
3-Month
1.5150 +13.53%
on 09/21/21
3.9500 -56.46%
on 08/25/21
-0.9000 (-34.35%)
since 06/24/21
52-Week
1.5150 +13.53%
on 09/21/21
6.7300 -74.44%
on 01/21/21
+0.0150 (+0.88%)
since 09/24/20

Most Recent Stories

More News
Aditxt, Inc. and SphereDX Launch AditxtScore(TM) for COVID-19 in Kentucky, Ohio and Indiana to Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster Shots

Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced a partnership with SphereDX, an advanced clinical diagnostic lab focusing...

ADTX : 1.7200 (-1.71%)
Aditxt Announces Closing of $11 Million Registered Direct Offering, and Funding of Bridge Loan Satisfying a Key Term of its Letter of Intent for Planned Acquisition of Commercial Stage Pharma Company with Anti-Viral COVID-19 Therapy

Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced it has closed on a registered direct offering for $11 million announced...

ADTX : 1.7200 (-1.71%)
Aditxt Announces Pricing of $11.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules

Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today that it has entered into definitive agreements with certain institutional...

ADTX : 1.7200 (-1.71%)
Is the Options Market Predicting a Spike in Aditxt (ADTX) Stock?

Investors need to pay close attention to Aditxt (ADTX) stock based on the movements in the options market lately.

ADTX : 1.7200 (-1.71%)
Aditxt, Inc. Signs Letter of Intent for Exclusive Rights to Negotiate the Acquisition of a Biopharmaceutical Company Commercializing and Distributing Antiviral Oral Therapy for COVID-19

Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced that it has signed a letter of intent ("the LOI") to acquire a biopharmaceutical...

ADTX : 1.7200 (-1.71%)
Aditxt, Inc. and Great Lakes Medical Laboratory Launch AditxtScore for COVID-19 in State of Michigan as a Personalized Approach to Addressing COVID-19 Pandemic

Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced a partnership with Great Lakes Medical Laboratory, Inc. (GLML), a full-service...

ADTX : 1.7200 (-1.71%)
Aditxt Provides Update on AditxtReprogramming's(TM) Apoptotic DNA Immunotherapy Therapeutic Platform

--Type 1 Diabetes and Skin Allografting are planned to enter clinical trials in 2022

ADTX : 1.7200 (-1.71%)
Aditxt Launches High-Sensitivity Neutralizing Antibody Test to Detect Individual Immune Response to COVID-19

Aditxt, Inc. ("Aditxt") (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced enhancements to its AditxtScore(TM) for COVID-19. A multi-dimensional...

ADTX : 1.7200 (-1.71%)
Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA

Aditxt, Inc. (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, today announced the opening of its AditxtScore(TM) Center in Richmond, VA. This high-capacity,...

ADTX : 1.7200 (-1.71%)
Aditxt Announces the Appointment of Dr. Lauren Chung to its Board of Directors

Aditx Therapeutics, Inc. ("Aditxt") (Nasdaq: ADTX), a biotech innovation company with a mission to improve the health of the immune system, announced today that Dr. Lauren Chung will join the Aditxt board...

ADTX : 1.7200 (-1.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Aditx Therapeutics Inc. is a life sciences company. It engages in developing biotechnologies specifically focused on health of the immune system through immune monitoring and reprogramming. Aditx Therapeutics Inc. is based in LOMA LINDA, CA.

See More

Key Turning Points

3rd Resistance Point 1.8833
2nd Resistance Point 1.8267
1st Resistance Point 1.7733
Last Price 1.7200
1st Support Level 1.6633
2nd Support Level 1.6067
3rd Support Level 1.5533

See More

52-Week High 6.7300
Fibonacci 61.8% 4.7379
Fibonacci 50% 4.1225
Fibonacci 38.2% 3.5071
Last Price 1.7200
52-Week Low 1.5150

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar